ClinicalTrials.gov record
Completed Phase 2 Interventional

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

ClinicalTrials.gov ID: NCT00000848

Public ClinicalTrials.gov record NCT00000848. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 4:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Antiviral Effect of Switching From Hard Capsule Saquinavir (SQVhc) to the Soft Gelatin Capsule of Saquinavir (SQVsc) Versus Switching to Indinavir (IDV) After 1 Year of Saquinavir Use

Study identification

NCT ID
NCT00000848
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
144 participants

Conditions and interventions

Conditions

Interventions

  • Indinavir sulfate Drug
  • Saquinavir Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Sep 30, 1998
Last update posted
Nov 3, 2021

Ends 1998

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Stanford CRS Palo Alto California 94304
Ucsf Aids Crs San Francisco California 94110
Harbor-UCLA Med. Ctr. CRS Torrance California 90502
University of Colorado Hospital CRS Aurora Colorado 80045
Univ. of Miami AIDS CRS Miami Florida 33136
Northwestern University CRS Chicago Illinois 60611
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Massachusetts General Hospital ACTG CRS Boston Massachusetts 02114
Washington U CRS St Louis Missouri 63110
St. Louis ConnectCare, Infectious Diseases Clinic St Louis Missouri 63112
SUNY - Buffalo, Erie County Medical Ctr. Buffalo New York 14260
Beth Israel Med. Ctr. (Mt. Sinai) New York New York 10003
NY Univ. HIV/AIDS CRS New York New York 10016
Univ. of Rochester ACTG CRS Rochester New York 14642
The Ohio State Univ. AIDS CRS Columbus Ohio 43210
University of Washington AIDS CRS Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000848, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000848 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →